• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期基于血液的微生物学检测对严重中风患者无效。

Early blood-based microbiological testing is ineffective in severe stroke patients.

机构信息

Department of Neurology, University Hospital of Heidelberg, Germany.

出版信息

J Neurol Sci. 2013 Feb 15;325(1-2):46-50. doi: 10.1016/j.jns.2012.11.014. Epub 2012 Dec 28.

DOI:10.1016/j.jns.2012.11.014
PMID:23273669
Abstract

BACKGROUND AND PURPOSE

Patients with severe acute stroke are at high risk for systemic infections which are associated with an increase in morbidity and mortality; nevertheless current guidelines do not recommend prophylactic antibiotic therapy. Sensitive detection of pathogens in the blood is desirable to guide early antibiotic therapy. We studied the yield of blood culture testing and microbiological PCR-based methods for early detection of post-stroke bacteremia.

METHODS

Serial blood culture tests either during the first fever episode (>38.5°C) or 24h after admission were performed every 12h for up to 96h after admission. Additionally, microbiological PCR-based techniques for the detection of microbiological pathogens were performed once during the first fever episode prior to initiating antibiotic treatment.

RESULTS

21 severely affected acute stroke patients deemed at high risk for systemic infections (median (interquartile range (IQR)) at admission NIHSSS 19 (15-30) were enrolled; 20 patients were intubated within 5h after ICU admission. All patients developed clinical signs and laboratory constellations compatible with systemic infections within 36h after admission. However, no patient had pathogenic bacteria either in serial blood culture analyses during the first 96h after admission or by PCR-based techniques.

CONCLUSIONS

Very early bacteremia seems not to be a feature of severe stroke in patients despite signs of early immune system depression and frequent subsequent evidence of infection including pneumonia. Consequently our data suggests, that routine early blood-based standard or molecular microbiological assays do not reveal bacteremia, this finding questions the usefulness of their routine performance in this context.

摘要

背景与目的

患有严重急性脑卒中的患者存在发生全身感染的高风险,这会增加发病率和死亡率;然而,目前的指南并不建议预防性使用抗生素治疗。在血液中敏感地检测病原体有助于指导早期抗生素治疗。我们研究了血液培养检测和基于微生物 PCR 的方法在检测卒中后菌血症方面的应用。

方法

在首次发热(>38.5°C)期间或入院后 24 小时内,每隔 12 小时进行一次连续的血培养检测,最长检测时间为入院后 96 小时。此外,在开始抗生素治疗前,在首次发热期间还进行了一次基于微生物 PCR 的技术检测以检测微生物病原体。

结果

21 名患有严重脑卒中且被认为存在全身感染高风险的患者(入院时 NIHSSS 中位数(四分位距(IQR))为 19(15-30)被纳入研究;20 名患者在入 ICU 后 5 小时内插管。所有患者在入院后 36 小时内均出现与全身感染相符的临床症状和实验室表现。然而,在入院后的前 96 小时内,连续的血培养分析或基于 PCR 的技术均未发现致病性细菌。

结论

尽管存在早期免疫系统抑制和随后经常出现感染的迹象,包括肺炎,但严重脑卒中患者似乎没有早期菌血症的特征。因此,我们的数据表明,常规的早期基于血液的标准或分子微生物学检测并不能发现菌血症,这一发现质疑了在这种情况下常规进行这些检测的有用性。

相似文献

1
Early blood-based microbiological testing is ineffective in severe stroke patients.早期基于血液的微生物学检测对严重中风患者无效。
J Neurol Sci. 2013 Feb 15;325(1-2):46-50. doi: 10.1016/j.jns.2012.11.014. Epub 2012 Dec 28.
2
Monitoring infection: from blood culture to polymerase chain reaction (PCR).监测感染:从血培养到聚合酶链反应(PCR)。
Best Pract Res Clin Anaesthesiol. 2013 Jun;27(2):279-88. doi: 10.1016/j.bpa.2013.06.010.
3
Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia.利用实时聚合酶链反应确定的细菌清除率作为及时替代标志物,评估重症鲍曼不动杆菌菌血症患者抗生素使用的适宜性。
Crit Care Med. 2012 Aug;40(8):2273-80. doi: 10.1097/CCM.0b013e3182515190.
4
Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia.多重聚合酶链反应检测增强菌血症和真菌血症的检测效果。
Crit Care Med. 2008 May;36(5):1487-92. doi: 10.1097/CCM.0b013e31816f487c.
5
Diagnostic techniques in bloodstream infections: where are we going?血流感染的诊断技术:我们将走向何方?
Int J Antimicrob Agents. 2009;34 Suppl 4:S9-12. doi: 10.1016/S0924-8579(09)70558-8.
6
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.头孢吡肟替代给药策略对阴沟肠杆菌、弗氏柠檬酸杆菌和铜绿假单胞菌所致肺部及血流感染的影响:一项单中心、开放标签、前瞻性观察性研究。
Clin Ther. 2009 Feb;31(2):299-310. doi: 10.1016/j.clinthera.2009.02.015.
7
Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer.儿童癌症患者中心静脉导管相关性血流感染的细菌 DNA 检测的准确性。
Health Technol Assess. 2011 Feb;15(7):1-114. doi: 10.3310/hta15070.
8
[Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].嗜麦芽窄食单胞菌引起的菌血症:一项临床流行病学研究及耐药情况分析
Rev Esp Quimioter. 1998 Sep;11(3):205-15.
9
[Microbiological sepsis screening in surgical ICU patients with the "lightCycler" Septifast test--a pilot study].[采用“LightCycler” Septifast检测法对外科重症监护病房患者进行微生物败血症筛查——一项初步研究]
Zentralbl Chir. 2009 Jun;134(3):249-53. doi: 10.1055/s-0028-1098776. Epub 2009 Jun 17.
10
Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.成人重症监护病房中与肺炎相关的医院血流感染中的抗菌药物耐药性及系统性监测培养的价值
Crit Care Med. 2006 Mar;34(3):653-9. doi: 10.1097/01.CCM.0000201405.16525.34.

引用本文的文献

1
Next-generation sequencing diagnostics of bacteremia in pediatric sepsis.儿童脓毒症中菌血症的下一代测序诊断
Medicine (Baltimore). 2021 Jun 25;100(25):e26403. doi: 10.1097/MD.0000000000026403.
2
Enhanced Performance of Next-Generation Sequencing Diagnostics Compared With Standard of Care Microbiological Diagnostics in Patients Suffering From Septic Shock.与标准护理微生物诊断相比,下一代测序诊断在患有败血症性休克的患者中的性能得到增强。
Crit Care Med. 2019 May;47(5):e394-e402. doi: 10.1097/CCM.0000000000003658.
3
Next-generation sequencing diagnostics of bacteremia in sepsis (Next GeneSiS-Trial): Study protocol of a prospective, observational, noninterventional, multicenter, clinical trial.
脓毒症中菌血症的下一代测序诊断(Next GeneSiS试验):一项前瞻性、观察性、非干预性、多中心临床试验的研究方案
Medicine (Baltimore). 2018 Feb;97(6):e9868. doi: 10.1097/MD.0000000000009868.
4
Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock-Results of a Combined Clinical and Experimental Investigation.脓毒性休克患者真菌病检测的免疫反应模式及下一代测序诊断——一项临床与实验联合研究的结果
Int J Mol Sci. 2017 Aug 18;18(8):1796. doi: 10.3390/ijms18081796.
5
Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study.蛋白质组学发现并验证血清淀粉样蛋白A作为中风后感染风险患者的预测标志物:一项试点研究。
Clin Proteomics. 2017 Jul 12;14:27. doi: 10.1186/s12014-017-9162-0. eCollection 2017.
6
Next-generation sequencing diagnostics of bacteremia in septic patients.脓毒症患者菌血症的新一代测序诊断
Genome Med. 2016 Jul 1;8(1):73. doi: 10.1186/s13073-016-0326-8.
7
Early prediction and outcome of septic encephalopathy in acute stroke patients with nosocomial coma.
J Clin Med Res. 2015 Jul;7(7):534-9. doi: 10.14740/jocmr2176w. Epub 2015 May 8.
8
Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases.急性脑血管病患者的应激介质和免疫功能障碍。
PLoS One. 2013 Sep 19;8(9):e74839. doi: 10.1371/journal.pone.0074839. eCollection 2013.